George Kunos
Impact in
- Pharmacology top 0.01%
- Cannabis and Cannabinoid Research
- Endocrine and Autonomic Systems top 0.05%
- Neuroscience of respiration and sleep
Papers in
- Pharmacology 137
- Cannabis and Cannabinoid Research 135
-
- Receptor Mechanisms and Signaling 52
- Co-authors
- Pál Pacher (41 shared papers)Sándor Bátkai (32 shared papers)K Varga (26 shared papers)Judith Harvey‐White (26 shared papers)Bin Gao (50 shared papers)Douglas Osei‐Hyiaman (24 shared papers)Jens A. Wagner (16 shared papers)Ken Mackie (15 shared papers)
- Journals
- British Journal of Pharmacology (16 papers)Journal of Biological Chemistry (15 papers)Proceedings of the National Academy of Sciences (12 papers)Hepatology (10 papers)Alcoholism Clinical and Experimental Research (8 papers)
- Partner nations
- United StatesCanadaHungary
In The Last Decade
George Kunos
288 papers receiving 27.0k citations
George Kunos's Hit Papers
Peers
Comparison fields: 5 of 146
- Pharmacology 16.7k
- Endocrine and Autonomic Systems 3.7k
- Toxicology 1.4k
- Cellular and Molecular Neuroscience 7.2k
- Endocrinology, Diabetes and Metabolism 4.6k
Countries citing papers authored by George Kunos
This map shows the geographic impact of George Kunos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Kunos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Kunos more than expected).
Fields of papers citing papers by George Kunos
This network shows the impact of papers produced by George Kunos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Kunos. The network helps show where George Kunos may publish in the future.
Co-authors
The 25 scholars most cited alongside George Kunos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 291 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Endocannabinoid System as an Emerging Target of Pharmacotherapy Hit paper breakdown → | 2006 | 1644 |
| 2 | International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 Hit paper breakdown → | 2010 | 1294 |
| 3 | Leptin-regulated endocannabinoids are involved in maintaining food intake Hit paper breakdown → | 2001 | 1255 |
| 4 | Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity Hit paper breakdown → | 2005 | 840 |
| 5 | Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity Hit paper breakdown → | 2005 | 789 |
| 6 | Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration Hit paper breakdown → | 2003 | 545 |
| 7 | Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Hit paper breakdown → | 1999 | 516 |
| 8 | Endocannabinoid signaling at the periphery: 50 years after THC Hit paper breakdown → | 2015 | 503 |
| 9 | 2001 | 435 | |
| 10 | 2008 | 381 | |
| 11 | 2010 | 368 | |
| 12 | 2006 | 353 | |
| 13 | 1998 | 341 | |
| 14 | Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes Hit paper breakdown → | 2013 | 329 |
| 15 | 2005 | 310 | |
| 16 | Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly Hit paper breakdown → | 2017 | 310 |
| 17 | 2012 | 299 | |
| 18 | 2013 | 291 | |
| 19 | 1996 | 288 | |
| 20 | 2001 | 286 |
About George Kunos
George Kunos is a scholar working on Pharmacology, Molecular Biology, Cellular and Molecular Neuroscience, Physiology and Endocrine and Autonomic Systems, having authored 291 papers that have together received 27.6k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (135 papers), Receptor Mechanisms and Signaling (52 papers), Neurotransmitter Receptor Influence on Behavior (36 papers), Alcohol Consumption and Health Effects (35 papers), Neuroscience and Neuropharmacology Research (33 papers), Diet, Metabolism, and Disease (32 papers), Neuroscience of respiration and sleep (28 papers) and Regulation of Appetite and Obesity (26 papers). The work is most often cited by research in Pharmacology (16.7k citations), Endocrine and Autonomic Systems (3.7k citations), Toxicology (1.4k citations), Cellular and Molecular Neuroscience (7.2k citations) and Endocrinology, Diabetes and Metabolism (4.6k citations). George Kunos has collaborated with scholars based in United States, Canada and Hungary. Frequent co-authors include Pál Pacher, Sándor Bátkai, K Varga, Judith Harvey‐White, Bin Gao, Douglas Osei‐Hyiaman, Jens A. Wagner, Ken Mackie, László Offertáler and Grzegorz Godlewski. Their work appears in journals such as British Journal of Pharmacology, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Hepatology and Alcoholism Clinical and Experimental Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.